Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market
Holding PRLD?
Track your performance easily

Prelude Therapeutics (PRLD) Balance Sheet

123 Followers

Prelude Therapeutics Balance Sheet

Prelude Therapeutics's total assets for Q2 2024 were $224.29M, a decrease of -9.23% from the previous quarter. PRLD total liabilities were $42.02M for the fiscal quarter, a 15.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 277.67M$ 220.50M$ 305.10M$ 223.59M$ 21.87M
Total Liabilities
$ 40.58M$ 25.06M$ 19.20M$ 11.41M$ 71.28M
Total Equity Gross Minority
$ 237.09M$ 195.44M$ 285.90M$ 212.18M$ -49.41M
Total Capitalization
$ 252.50M$ 195.44M$ 285.90M$ 212.18M$ -49.41M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 0.00$ 258.00K
Currency in USD

Prelude Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis